Curis elects Anne E. Borgman, M.D. to board of directors

CURIS INC

Anne E. Borgman, M.D. elected as Class I director effective Oct 12, 2022, term until 2024 annual meeting.
She will serve on the Nominating and Corporate Governance Committee immediately.
Granted one-time option for 25,000 shares vesting over 4 years with 10-year term.
Entered standard indemnification agreement with Curis consistent with other non-employee directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anne E. Borgman, M.D.

Class I Director

CRIS · CURIS INC

Effective: 2022-10-12
Filed: October 14, 2022, 7:59 PM ET

On October 12, 2022 , the Board of Directors (“Board”) of Curis, Inc. (the “Company”) elected Anne E. Borgman, M.D., to serve as a class I director until the 2024 Annual Meeting of Stockholders and thereafter until her successor is duly elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anne E. Borgman, M.D. was elected as Class I Director at CURIS INC.

Action: elected
Role: Class I Director

Exact text from the filing

On October 12, 2022 , the Board of Directors (“Board”) of Curis, Inc. (the “Company”) elected Anne E. Borgman, M.D., to serve as a class I director until the 2024 Annual Meeting of Stockholders and thereafter until her successor is duly elected and qualified.

View on SEC.gov

CURIS INC filing history →

Source: SEC EDGAR

accession 0001108205-22-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.